$0.826
Insights on Zepp Health Corp
Revenue is down for the last 3 quarters, 1.07B → 602.09M (in $), with an average decrease of 23.3% per quarter
Netprofit is up for the last 4 quarters, -133.98M → 2.97M (in $), with an average increase of 845.6% per quarter
In the last 1 year, Vizio Holding Corp has given 21.1% return, outperforming this stock by 60.8%
1.2%
Downside
Day's Volatility :4.64%
Upside
3.48%
1.2%
Downside
52 Weeks Volatility :60.95%
Upside
60.48%
Period | Zepp Health Corp | Sector (Technology) | Index (Russel 2000) |
---|---|---|---|
3 Months | -46.74% | 1.6% | 0.0% |
6 Months | -22.84% | 18.6% | 0.0% |
1 Year | -39.74% | 32.9% | -1.5% |
3 Years | -91.96% | 38.8% | -21.8% |
Market Capitalization | 51.9M |
Book Value | $41.28 |
Earnings Per Share (EPS) | -0.64 |
Wall Street Target Price | 3.93 |
Profit Margin | -8.5% |
Operating Margin TTM | 0.89% |
Return On Assets TTM | -2.65% |
Return On Equity TTM | -8.19% |
Revenue TTM | 2.5B |
Revenue Per Share TTM | 41.05 |
Quarterly Revenue Growth YOY | -44.0% |
Gross Profit TTM | 1.3B |
EBITDA | -148.5M |
Diluted Eps TTM | -0.64 |
Quarterly Earnings Growth YOY | -0.68 |
EPS Estimate Current Year | 0.07 |
EPS Estimate Next Year | 0.16 |
EPS Estimate Current Quarter | 0.03 |
EPS Estimate Next Quarter | 0.05 |
What analysts predicted
Upside of 375.79%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 530.1M | ↑ 77.92% |
Net Income | 49.4M | ↑ 102.79% |
Net Profit Margin | 9.33% | ↑ 1.15% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 832.0M | ↑ 59.44% |
Net Income | 82.3M | ↑ 69.15% |
Net Profit Margin | 9.9% | ↑ 0.57% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 986.4M | ↑ 10.69% |
Net Income | 35.1M | ↓ 60.23% |
Net Profit Margin | 3.56% | ↓ 6.34% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 980.9M | ↓ 2.85% |
Net Income | 15.1M | ↓ 58.07% |
Net Profit Margin | 1.53% | ↓ 2.03% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 600.7M | ↓ 33.72% |
Net Income | -44.5M | ↓ 419.69% |
Net Profit Margin | -7.4% | ↓ 8.93% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↓ 28.37% |
Net Income | -279.2M | ↓ 8.94% |
Net Profit Margin | -9.41% | ↓ 2.01% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 165.4M | ↓ 33.3% |
Net Income | -17.7M | ↓ 426.67% |
Net Profit Margin | -10.7% | ↓ 12.89% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 169.3M | ↑ 8.8% |
Net Income | -2.9M | ↓ 82.61% |
Net Profit Margin | -1.71% | ↑ 8.99% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 93.5M | ↓ 46.49% |
Net Income | -19.4M | ↑ 549.58% |
Net Profit Margin | -20.77% | ↓ 19.06% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 156.0M | ↑ 66.11% |
Net Income | -10.9M | ↓ 44.0% |
Net Profit Margin | -7.0% | ↑ 13.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 89.4M | ↓ 39.51% |
Net Income | -9.6M | ↓ 6.79% |
Net Profit Margin | -10.79% | ↓ 3.79% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 602.1M | ↓ 7.13% |
Net Income | 3.0M | ↓ 104.25% |
Net Profit Margin | 0.49% | ↑ 11.28% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 1.5B | ↑ 49.57% |
Total Liabilities | 1.2B | ↑ 31.09% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 473.8M | ↑ 123.93% |
Total Liabilities | 210.7M | ↑ 17.24% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 740.8M | ↑ 58.81% |
Total Liabilities | 383.2M | ↑ 84.77% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 905.2M | ↑ 14.09% |
Total Liabilities | 486.6M | ↑ 18.54% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 955.0M | ↑ 3.08% |
Total Liabilities | 494.7M | ↓ 0.67% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 763.8M | ↓ 13.44% |
Total Liabilities | 374.5M | ↓ 18.06% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 910.7M | ↑ 0.27% |
Total Liabilities | 496.7M | ↑ 5.58% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 817.1M | ↓ 4.6% |
Total Liabilities | 426.4M | ↓ 8.72% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 710.3M | ↓ 15.84% |
Total Liabilities | 339.6M | ↓ 22.9% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 766.7M | ↑ 7.53% |
Total Liabilities | 375.9M | ↑ 10.27% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 679.8M | ↓ 6.41% |
Total Liabilities | 332.6M | ↓ 6.6% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.8B | ↓ 1.96% |
Total Liabilities | 2.3B | ↓ 4.77% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 238.3M | ↑ 1280.38% |
Investing Cash Flow | -38.9M | ↓ 60.88% |
Financing Cash Flow | 20.1M | ↑ 100.41% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 102.9M | ↑ 196.89% |
Investing Cash Flow | -47.2M | ↑ 735.47% |
Financing Cash Flow | 92.9M | ↑ 3081.69% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 61.3M | ↓ 39.51% |
Investing Cash Flow | -16.1M | ↓ 65.31% |
Financing Cash Flow | 3.7M | ↓ 95.99% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.1M | ↓ 63.25% |
Investing Cash Flow | -31.7M | ↑ 83.56% |
Financing Cash Flow | 86.6M | ↑ 2104.97% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -36.5M | ↓ 247.76% |
Investing Cash Flow | -167.8M | ↑ 416.86% |
Financing Cash Flow | 86.5M | ↓ 2.41% |
Q2 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 0.0 | - |
Investing Cash Flow | 0.0 | - |
Financing Cash Flow | 0.0 | - |
Q3 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 0.0 | - |
Investing Cash Flow | 0.0 | - |
Financing Cash Flow | 0.0 | - |
Q4 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 0.0 | - |
Investing Cash Flow | 0.0 | - |
Financing Cash Flow | 0.0 | - |
Sell
Neutral
Buy
Zepp Health Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Zepp Health Corp | -32.33% | -22.84% | -39.74% | -91.96% | -95.01% |
Apple, Inc. | -3.29% | -4.46% | 0.92% | 24.59% | 229.64% |
Vizio Holding Corp | -3.85% | 106.33% | 21.06% | -58.95% | -58.95% |
Lg Display Co., Ltd. | -8.19% | -14.57% | -39.23% | -65.11% | -60.48% |
Sony Corporation | -8.37% | -3.0% | -10.66% | -25.82% | 70.46% |
Sonos, Inc. | -4.71% | 49.34% | -17.05% | -60.34% | 43.53% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Zepp Health Corp | 9.5 | NA | NA | 0.07 | -0.08 | -0.03 | NA | 41.28 |
Apple, Inc. | 26.34 | 26.34 | 2.08 | 6.55 | 1.54 | 0.21 | 0.01 | 4.79 |
Vizio Holding Corp | 76.43 | 76.43 | 1.46 | 0.23 | 0.07 | 0.02 | NA | 2.27 |
Lg Display Co., Ltd. | 53.62 | NA | 0.5 | -0.9 | -0.26 | -0.04 | NA | 20212.03 |
Sony Corporation | 18.4 | 18.4 | 4.35 | 4.93 | 0.12 | 0.02 | 0.01 | 5937.71 |
Sonos, Inc. | 101.4 | NA | NA | 0.25 | -0.01 | 0.0 | NA | 4.77 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Zepp Health Corp | Buy | $51.9M | -95.01% | 9.5 | -8.5% |
Apple, Inc. | Buy | $2.7T | 229.64% | 26.34 | 26.16% |
Vizio Holding Corp | Buy | $2.1B | -58.95% | 76.43 | 1.68% |
Lg Display Co., Ltd. | Buy | $3.8B | -60.48% | 53.62 | -12.82% |
Sony Corporation | Buy | $102.4B | 70.46% | 18.4 | 6.5% |
Sonos, Inc. | Buy | $2.1B | 43.53% | 101.4 | -0.28% |
Allspring Global Investments Holdings, LLC
Fidelity International Ltd
SEI Investments Co
Citadel Advisors Llc
Renaissance Technologies Corp
Millennium Management LLC
zepp health (nyse: zepp), is a global smart wearable and health technology leader, that empowers users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading brands such as amazfit., zepp clarity and zepp aura. powered by its proprietary zepp digital health management platform, which includes the zepp os, ai chips, biometric sensors, and data algorithms, zepp delivers 24/7 actionable insights and guidance to help users attain their wellness goals. the company has also applied its ai expertise to emerging industrial medical imaging technologies and delivers big data and analytics capabilities to support medical and diagnostics care service providers. zepp has shipped 200 million units to date and its products are available in 90+ countries. founded in 2013 as huami corp., the company became zepp health corporation in february 2021. zepp has 1,300+ team members and offices across the north america, emea, and apac regions. for more
Organization | Zepp Health Corp |
Employees | 0 |
CEO | Mr. Wang Huang |
Industry | Technology |